126 related articles for article (PubMed ID: 9299755)
1. New polyazole derivatives from 2-(2,4-dichlorophenyl)-1,3-dioxolane. Antifungal activity. Structure-activity relationships.
Delcourt A; Mathieu G; Baji H; Kimny T; Flammang M; Compagnon PL
Mycopathologia; 1997; 137(1):27-32. PubMed ID: 9299755
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study of the antimycotic effect of clotrimazole in vitro and in vivo when administered locally].
Plempel M; Bartmann K
Arzneimittelforschung; 1972 Aug; 22(8):1280-9. PubMed ID: 4678389
[No Abstract] [Full Text] [Related]
3. Antifungal sordarins. Synthesis and structure-activity relationships of 3',4'-fused dioxolane and dioxane derivatives.
Bueno JM; Cuevas JC; Fiandor JM; García-Ochoa S; Gómez de las Heras F
Bioorg Med Chem Lett; 2002 Jan; 12(2):121-4. PubMed ID: 11755335
[TBL] [Abstract][Full Text] [Related]
4. [In vitro antifungal activity of omoconazole nitrate, a new imidazole antimycotic].
Itoyama T; Aoki Y; Hiratani T; Uchida K; Yamaguchi H
Jpn J Antibiot; 1993 Sep; 46(9):773-80. PubMed ID: 8254897
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
Gebhart RJ; Espinel-Ingroff A; Shadomy S
Chemotherapy; 1984; 30(4):244-7. PubMed ID: 6086246
[TBL] [Abstract][Full Text] [Related]
6. [Econazole nitrate. In vitro tests and clinical trial].
Dorn M; Scherwitz C; Lentze I; Plewig G
MMW Munch Med Wochenschr; 1975 Apr; 117(16):687-92. PubMed ID: 805931
[TBL] [Abstract][Full Text] [Related]
7. Anticandidal and antidermatophytic activity of Cinnamomum species essential oils.
Mastura M; Nor Azah MA; Khozirah S; Mawardi R; Manaf AA
Cytobios; 1999; 98(387):17-23. PubMed ID: 10490360
[No Abstract] [Full Text] [Related]
8. Synthesis and antifungal activity of new thienyl and aryl conazoles.
Chevreuil F; Landreau A; Seraphin D; Larcher G; Bouchara JP; Richomme P
J Enzyme Inhib Med Chem; 2006 Jun; 21(3):293-303. PubMed ID: 16918077
[TBL] [Abstract][Full Text] [Related]
9. Anti-protozoal and anti-fungal evaluation of 3,5-disubstituted 1,2-dioxolanes.
Pinet A; Cojean S; Nguyen LT; Vásquez-Ocmín P; Maciuk A; Loiseau PM; Le Pape P; Figadère B; Ferrié L
Bioorg Med Chem Lett; 2021 Sep; 47():128196. PubMed ID: 34116159
[TBL] [Abstract][Full Text] [Related]
10. Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivatives.
Mullen GB; DeCory TR; Mitchell JT; Allen SD; Kinsolving CR; Georgiev VS
J Med Chem; 1988 Oct; 31(10):2008-14. PubMed ID: 3172137
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Carrillo-Muñoz AJ; Guglietta A; Palacín C; Casals J; del Valle O; Guardià C; Rodríguez V; Quindós G
Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
[TBL] [Abstract][Full Text] [Related]
12. Antifungal activity of saperconazole (R 66 905) in vitro.
Odds FC
J Antimicrob Chemother; 1989 Oct; 24(4):533-7. PubMed ID: 2613602
[TBL] [Abstract][Full Text] [Related]
13. [Antifungal activity of the components of the drug cerbiden of plant origin].
Smirnov VV; Bondarenko AS; Gladun NP
Mikrobiol Z; 2003; 65(4):17-22. PubMed ID: 14618782
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of novel azoles as potent antifungal agents.
Li L; Ding H; Wang B; Yu S; Zou Y; Chai X; Wu Q
Bioorg Med Chem Lett; 2014 Jan; 24(1):192-4. PubMed ID: 24332489
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antifungal activity, and molecular modeling studies of new inverted oxime ethers of oxiconazole.
Rossello A; Bertini S; Lapucci A; Macchia M; Martinelli A; Rapposelli S; Herreros E; Macchia B
J Med Chem; 2002 Oct; 45(22):4903-12. PubMed ID: 12383016
[TBL] [Abstract][Full Text] [Related]
16. A new antimycotic from bayer AG, Bay b 5097. In vitro experiments with strains of the species Candida, Torulopsis, and Cryptococcus.
Bodenhoff J
Acta Pathol Microbiol Scand B Microbiol Immunol; 1971; 79(3):345-8. PubMed ID: 5283059
[No Abstract] [Full Text] [Related]
17. [In vitro antifungal activity of rilopirox, a new hydroxypyridone antimycotic agent].
Harada I; Mitsui K; Uchida K; Yamaguchi H
Jpn J Antibiot; 1997 Feb; 50(2):195-9. PubMed ID: 9100079
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and structure-activity relationship studies of novel thienopyrrolidone derivatives with strong antifungal activity against Aspergillus fumigates.
Cao X; Xu Y; Cao Y; Wang R; Zhou R; Chu W; Yang Y
Eur J Med Chem; 2015 Sep; 102():471-6. PubMed ID: 26310892
[TBL] [Abstract][Full Text] [Related]
19. Antifungal agents. VI. In vitro antifungal activities of halobenzoyl esters of cis- and trans-[2-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]carbinols.
Stefancich G; Silvestri R; Pagnozzi E; Artico M; Retico A; Apuzzo G; Simonetti N
Farmaco; 1993 Aug; 48(8):1103-12. PubMed ID: 8216672
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of in vitro antifungal activity of N-benzylsalicylamide derivatives.
Kubanová P; Buchta V; Perina M; Waisser K; Pour M
Folia Microbiol (Praha); 2003; 48(3):346-50. PubMed ID: 12879744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
